vs
芝商所(CME)与Roper Technologies(ROP)财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是芝商所的1.1倍($2.1B vs $1.9B),Roper Technologies净利率更高(15.8% vs 0.1%,领先15.7%),芝商所同比增速更快(14.5% vs 11.3%),过去两年芝商所的营收复合增速更高(10.8% vs 10.5%)
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业,为全球规模最大的金融衍生品交易所运营商,旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台,覆盖农产品、货币、能源等品类交易,同时持有标普道琼斯指数27%的股权。
罗珀技术公司是一家专注于科技领域的控股企业,通过持有并运营多家不同细分赛道的科技公司,在科技产业投资与资产管理领域形成了成熟的业务体系,在全球相关市场具备较高的行业影响力。
CME vs ROP — 直观对比
营收规模更大
ROP
是对方的1.1倍
$1.9B
营收增速更快
CME
高出3.2%
11.3%
净利率更高
ROP
高出15.7%
0.1%
两年增速更快
CME
近两年复合增速
10.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.9B | $2.1B |
| 净利润 | $1.2M | $331.0M |
| 毛利率 | — | 69.4% |
| 营业利润率 | 0.1% | 27.2% |
| 净利率 | 0.1% | 15.8% |
| 营收同比 | 14.5% | 11.3% |
| 净利润同比 | 20.7% | 842.6% |
| 每股收益(稀释后) | — | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CME
ROP
| Q1 26 | $1.9B | $2.1B | ||
| Q4 25 | $1.6B | $2.1B | ||
| Q3 25 | $1.5B | $2.0B | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.6B | $1.9B | ||
| Q4 24 | $1.5B | $1.9B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.5B | $1.7B |
净利润
CME
ROP
| Q1 26 | $1.2M | $331.0M | ||
| Q4 25 | $1.2B | $428.4M | ||
| Q3 25 | $908.0M | $398.5M | ||
| Q2 25 | $1.0B | $378.3M | ||
| Q1 25 | $956.2M | $331.1M | ||
| Q4 24 | $874.6M | $462.3M | ||
| Q3 24 | $912.8M | $367.9M | ||
| Q2 24 | $883.2M | $337.1M |
毛利率
CME
ROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | — | 69.5% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 68.7% | ||
| Q4 24 | — | 68.3% | ||
| Q3 24 | — | 69.2% | ||
| Q2 24 | — | 69.5% |
营业利润率
CME
ROP
| Q1 26 | 0.1% | 27.2% | ||
| Q4 25 | 61.8% | 28.6% | ||
| Q3 25 | 63.3% | 28.4% | ||
| Q2 25 | 66.7% | 28.2% | ||
| Q1 25 | 67.5% | 27.9% | ||
| Q4 24 | 62.1% | 28.0% | ||
| Q3 24 | 64.6% | 28.1% | ||
| Q2 24 | 65.3% | 28.8% |
净利率
CME
ROP
| Q1 26 | 0.1% | 15.8% | ||
| Q4 25 | 71.7% | 20.8% | ||
| Q3 25 | 59.1% | 19.8% | ||
| Q2 25 | 60.6% | 19.5% | ||
| Q1 25 | 58.2% | 17.6% | ||
| Q4 24 | 57.3% | 24.6% | ||
| Q3 24 | 57.6% | 20.8% | ||
| Q2 24 | 57.6% | 19.6% |
每股收益(稀释后)
CME
ROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $3.24 | $3.97 | ||
| Q3 25 | $2.49 | $3.68 | ||
| Q2 25 | $2.81 | $3.49 | ||
| Q1 25 | $2.62 | $3.06 | ||
| Q4 24 | $2.40 | $4.29 | ||
| Q3 24 | $2.50 | $3.40 | ||
| Q2 24 | $2.42 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $382.9M |
| 总债务越低越好 | $3.4B | $9.7B |
| 股东权益账面价值 | — | $18.8B |
| 总资产 | $202.0B | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势,按日历期对齐
现金及短期投资
CME
ROP
| Q1 26 | $2.4B | $382.9M | ||
| Q4 25 | $4.5B | $297.4M | ||
| Q3 25 | $2.6B | $320.0M | ||
| Q2 25 | $2.1B | $242.4M | ||
| Q1 25 | $1.5B | $372.8M | ||
| Q4 24 | $3.0B | $188.2M | ||
| Q3 24 | $2.4B | $269.6M | ||
| Q2 24 | $1.9B | $251.5M |
总债务
CME
ROP
| Q1 26 | $3.4B | $9.7B | ||
| Q4 25 | — | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
CME
ROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $28.7B | $19.9B | ||
| Q3 25 | $28.2B | $20.0B | ||
| Q2 25 | $27.7B | $19.6B | ||
| Q1 25 | $27.0B | $19.2B | ||
| Q4 24 | $26.5B | $18.9B | ||
| Q3 24 | $28.2B | $18.5B | ||
| Q2 24 | $27.6B | $18.1B |
总资产
CME
ROP
| Q1 26 | $202.0B | $34.6B | ||
| Q4 25 | $198.4B | $34.6B | ||
| Q3 25 | $187.1B | $34.6B | ||
| Q2 25 | $179.9B | $33.2B | ||
| Q1 25 | $157.8B | $31.4B | ||
| Q4 24 | $137.4B | $31.3B | ||
| Q3 24 | $137.8B | $31.6B | ||
| Q2 24 | $123.4B | $29.8B |
负债/权益比
CME
ROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | — | $507.0M |
| 自由现金流率自由现金流/营收 | — | 24.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CME
ROP
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $738.0M | ||
| Q3 25 | $968.1M | $869.5M | ||
| Q2 25 | $1.1B | $404.1M | ||
| Q1 25 | $1.1B | $528.7M | ||
| Q4 24 | $1.0B | $722.2M | ||
| Q3 24 | $1.0B | $755.4M | ||
| Q2 24 | $776.9M | $384.1M |
自由现金流
CME
ROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $949.7M | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $991.7M | — | ||
| Q3 24 | $973.2M | — | ||
| Q2 24 | $758.7M | — |
自由现金流率
CME
ROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 61.8% | — | ||
| Q2 25 | 61.5% | — | ||
| Q1 25 | 67.1% | — | ||
| Q4 24 | 65.0% | — | ||
| Q3 24 | 61.4% | — | ||
| Q2 24 | 49.5% | — |
资本支出强度
CME
ROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 1.2% | — |
现金转化率
CME
ROP
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | 1.72× | ||
| Q3 25 | 1.07× | 2.18× | ||
| Q2 25 | 1.03× | 1.07× | ||
| Q1 25 | 1.17× | 1.60× | ||
| Q4 24 | 1.16× | 1.56× | ||
| Q3 24 | 1.10× | 2.05× | ||
| Q2 24 | 0.88× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图